Skip to content

A Pilot Study for Adaptation of Neospot Device for Health Care at Primary Health Facilities in Kenya

A Pilot Study for the Adaptation of Neospot Device for Health Care Among Out-Patients at Primary Health Facilities in Nairobi and Kajiado Counties, Kenya

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06132633
Enrollment
159
Registered
2023-11-15
Start date
2023-12-31
Completion date
2024-04-30
Last updated
2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbidity

Keywords

Morbidity, Vitals Measurement, Health

Brief summary

Neospot device is a 5-in-1 wearable vital signs monitor designed to measure temperature, blood pressure, pulse rate (PR), respiratory rate (RR) and blood oxygen saturation (SPO2). We propose to study the experiences of patients and nurses regarding spot measurement of vital signs at the outpatient department in primary care facilities in Kenya. The study aims to investigate the capability, opportunity, and motivation of nurses to use the Neospot device for vital signs measurement in level 3 facilities in Kenya by validating the accuracy of the Neospot and assessing the experience of patients while using the Neospot, the study also aims to assess the experiences of nurses as they use the Neospot and determine how the Neospot affects their workflow.

Detailed description

This study intends to investigate the experiences of both nurses and patients in the use of a specific brand of such a device known as the 'neospot' device in various sub county, health centres in Kenya. The study also aims at finding out whether the device affects the rate and efficiency of how nurses work in these facilities. The study will apply a cross sectional design, three facilities will be used as the sampling frame two urban facilities from Nairobi County and one peri urban rural facility from Kajiado county. The participants will be selected randomly. Data will be obtained from a total of 159 randomly selected patients, all the nurses who will be on duty will also be included as participants in the study and the team leaders will be interviewed as key informants for qualitative data. Quantitative data will be analysed using SPSS version 24 for descriptive and inferential statistics, NVIVO software will be used to analyse the qualitative data to determine the themes. Study Duration: Data collection, analysis and report writing will take 4 ½ months.

Interventions

DEVICENeospot vitals measurement

Vitals of participants in the intervention group will be measured using neospot alongside standard of care measurement.

Sponsors

Amref Health Africa
CollaboratorOTHER
Neopenda, PBC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This is a cross-sectional study design. All participants receive the same intervention of our Neospot vitals measurements.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Participants between 18 and 70 years of age * In stable condition * Willing to give consent to participate in the study

Exclusion criteria

* Very ill and unstable patients who need emergency care * Patients with medical conditions that are characterized by rapid changes in vital signs such as thyroid disorders * Patients who have skin lesions on the forehead where the device is to be fixed

Design outcomes

Primary

MeasureTime frameDescription
Capability, opportunity and motivation of nurses to use the Neospot device for vital signs measurementFrom enrolment, monitoring, data extraction and analysis over a period of 4 monthsNumber of nurses reporting positive experiences and improved workflow as a result of utilizing the neospot product as responded in surveys

Secondary

MeasureTime frameDescription
Accuracy of vitals measurement of Neospot device compared to traditional equipmentFrom enrolment, monitoring, data extraction and analysis over a period of 4 monthsWe want to validate the accuracy of the Neospot device to measure temperature, SPO2, pulse rate and respiratory rate by comparing similarities and differences to the traditional devices vital signs readings
Experiences of patients using the Neospot vitals measurement deviceFrom enrolment, monitoring, data extraction and analysis over a period of 4 monthsNumber of patients reporting positive experience with our Neospot device through surveys
Acceptability of Neospot device by nurses for adoption in health facilitiesFrom enrolment, monitoring, data extraction and analysis over a period of 4 monthsNumber of nurses willingness to adopt the use the Neospot device as their primary vital sign measurement tool post utilization, determined through surveys
Effects of Neospot vitals measurement device on nurses' workflowFrom enrolment, monitoring, data extraction and analysis over a period of 4 monthsNumber of nurses reporting positive impact of the Neospot device on efficiency and improved workflow through surveys

Countries

Kenya

Contacts

Primary ContactAssumpta S Nantume, MSc
assumpta@neopenda.com+256755098873
Backup ContactSona R Shah, MSc
sona@neopenda.com+19196222478

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026